KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Cost Of Revenue: 2017-2025

Historic Cost of Revenue for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $127.4 million.

  • Guardant Health's Cost of Revenue rose 30.13% to $127.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $456.0 million, marking a year-over-year increase of 34.41%. This contributed to the annual value of $364.9 million for FY2024, which is 23.61% up from last year.
  • Latest data reveals that Guardant Health reported Cost of Revenue of $127.4 million as of Q3 2025, which was up 6.51% from $119.6 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cost of Revenue ranged from a high of $127.4 million in Q3 2025 and a low of $34.3 million during Q1 2021.
  • Over the past 3 years, Guardant Health's median Cost of Revenue value was $81.9 million (recorded in 2024), while the average stood at $91.9 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 100.15% in 2021, then fell by 14.23% in 2023.
  • Over the past 5 years, Guardant Health's Cost of Revenue (Quarterly) stood at $59.6 million in 2021, then skyrocketed by 36.62% to $81.4 million in 2022, then dropped by 2.82% to $79.1 million in 2023, then surged by 32.40% to $104.8 million in 2024, then spiked by 30.13% to $127.4 million in 2025.
  • Its Cost of Revenue stands at $127.4 million for Q3 2025, versus $119.6 million for Q2 2025 and $104.3 million for Q1 2025.